Stem cell-based products for veterinary use: specific questions on target animal safety to be addressed by the Ad Hoc Expert Group on Veterinary Novel Therapies (ADVENT)

Veterinary Regulatory and procedural guidance Scientific guidelines

This problem statement provides the basis for development of a guidance on target animal safety in relation to stem cell products intended for veterinary use. If you have any comments on the content of the document, use this. The completed comments form should be sent to vet-guidelines@ema.europa.eu.

Keywords: animal stem cell -based products (ASCP), target animal safety (TAS) studies, veterinary, mesenchymal

Share this page